Inquiry into Murine and Human Lupus

Immunological Reviews

Volumn 144, Issue 1, 1995, Pages 157-193

  KUNMAN, DEFWIS M ^a   STEINBERG, ALFRED D ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b MITRE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; COMPARATIVE STUDY; HUMAN; IMMUNOLOGY; MOUSE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL CELL; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; CROSS REACTION; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; COMPARATIVE STUDY; HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE;

AUTOANTIBODY; CYTOKINE;

EID: 0028990471     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1995.tb00069.x     Document Type: Article

References (165)

1. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr/lpr mice
2. Cytokine profile in SLE, RA and other rheumatic diseases
3. Nucleosome‐restricted antibodies are detected before anti‐dsDNA and/or antihistone antibodies
4. 1 murine SLE model
5. Spontaneous murine lupus‐like syndromes. Clinical and immunopalhological manifestations in several strains
6. The cytokine network
7. Increased multicional antibody‐forming cell activity in the peripheral blood of patients with SLE
8. Autoantibodies to cytokines ‐friends or foes
9. Elevated immunoglobulin secreting cells in the blood of patients with active systemic lupus erythematosus: correlation of laboratory and clinical assessment of disease activity
10. Prevention of T cell anergy by signaling through the gamma‐c chain of the IL‐2 receptor
11. Increased spontaneous activity of antibody‐forming cells in the peripheral blood of patients with active systemic lupus erythematosus
12. Genesis and evolution of antichromatin autoantibodies in murine lupus
13. The central role of chromatin in autoimmune responses in histones and DNA in SLE
14. +B lymphocytes, polyreactive antibodies and the human B cell repertoire
15. Characterization of multireactive auto‐antibody and identification of Leu‐1 B lymphocytes as cells making antibodies binding multiple self and exogeneous molecules
16. Nuclear DNA degradation in lymphocytes of patients with systemic lupus erythematosus
17. The effect of prior intragastric antigen administration on primary and secondary anti‐ovalbumin responses of C57BL/ 6 and NZB mice
18. B cells; response to fresh and effector T helper cells: role of cognate T‐B interaction and the cytokines IL‐2, IL‐4 and IL‐6
19. Induction of a cationic shift in IgG anti‐DNA autoantibodies: role of helper T cells with classical and novel phenotypes in three murine models of lupus nephritis
20. Assessment of clinical parameters associated with increased frequency of mutant T cells in patients with systemic lupus erythematosus
21. Antigen‐specific induction of antibodies against mammalian DNA in non‐autoimmune mice
22. Murine hybridomas secreting natural monoclonal antibodies reactive with self antigens
23. High frequency of natural autoantibodies in normal newborn mice
24. Relationship of IL‐4 to isotypic distribution of anti‐DS DNA antibodies in SLE
25. Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus
26. Isotype progression and clonality of anti‐Sm autoantibodies in MRL/Mp‐lpr/lpr mice
27. Mechanism of photosensitivity in systemic lupus erythematosus patients
28. Expression on anti‐DNA immunoglobulin transgenes in non‐autoimmune mice
29. Interferon gamma regulates the isotype of Ig secreting during in vivo humoral responses
30. B cells turn off virgin but not memory T cells
31. Receptor editing: an approach by autoreactive B cells to escape tolerance
32. Assessment of in vivo frequency of mutated T‐cells in patients with systemic lupus erythematosus
33. Increased susceptibility to in vitro ultraviolet B radiation in fibroblasts and lymphocytes cultured from systemic lupus erythematous patients
34. Altered immunoglobulin expression and functional silencing of self‐reactive B cells in transgenic mice
35. Transgenic mice and analysis of B‐ceil tolerance
36. Naturally occurring antibodies against nine common antigens in human sera
37. Cytokine abnormalities in SLE
38. Induction of severe autoimmune disease in normal mice by simultaneous action of multiple immunostimul‐ators
39. Usage of a novel class of germ‐line Ig variable region gene for cationic anti‐DNA autoantibodies in human lupus nephritis
40. The lupus autoantigens and the pathogenesis of SLE
41. Elimination from peripheral lymphoid tissues of self‐reactive B lymphocytes recognizing membrane‐bound antigens
42. Elimination of self‐reactive B lymphocytes proceeds in two stages: arrested development and cell death
43. Normal, autoimmune and malignant CD5 B cells: the Ly‐1 lineage
44. + lymphocytes in vivo during healing and progressive murine leishmaniasis
45. Increased autoantibody production by NZB/NZW B cells in response to IL‐5
46. Selection of the T cell receptor repertoire in lpr mice
47. Human B‐cell differentiation factor defined by anti‐peptide antibody and its possible role in autoantibody production
48. The reaction of the lupus erythematosus (LE) cell factor with deoxyribonucleoprotein of the nucleus
49. Activated T lymphocytes in the peripheral blood of patients with systemic lupus erythematosus induce B cells to produce immunoglobulin
50. Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease
51. Precocious and enhanced functional maturation of B lineage cells in New Zealand black mice during embryonic development
52. Comparative analysis of natural antibody specificities among hybridomas originating from spleen and peritoneal cavity of adult NZB and BALB/c mice
53. Interaction of mutant lpr gene with background strain influences renal disease
54. Regulation of B cell activation in autoimmune mice
55. Polyclonal B cell activation in lupus‐prone mice precedes and predicts the development of autoimmune disease
56. IgGl and IgG2a production by autoimmune B cells treated in vitro with IL‐4 and IFN‐gamma
57. Analysis of B lymphocytes cross‐reactivity at the single cell level
58. Cross‐reactivity of IgM secreting B cells from normal BALB/c mice
59. Cross‐reactivity of IgG and IgM secreting B cells in normal and autoimmune mice
60. Natural murine auto‐antibodies and conventional antibodies exhibit similar degrees of antigenic cross‐reactivity
61. Development of the autoimmune B cell repertoire in MRL‐lpr/lpr mice
62. Acquisition and maturation of expressed B cell repertoires in normal and autoimmune mice
63. Cross‐reactivity of IgG anti‐DNA secreting B cells in patients with systemic lupus erythematosus
64. Systemic autoimmune disease arises from poly‐clonal B cell activation
65. Similar in vivo expansion of B cells from normal DBAy2 and autoimmune NZB mice in xid recipients
66. The specificity repertoire of prereceptor and mature B cells
67. Analysis of thymic endogenous retroviral expression in murine lupus: Genetic and immune studies
68. Association of murine lupus and thymic full‐length endogenous retroviral expression maps to a bone marrow stem cell
69. B ceil activation induced by oligodeoxynucleotides or DNA containing un‐methylated CpG motifs
70. Pathogenesis of the glomerulonephritis of NZBAV mice
71. Studies of detective tolerance in murine lupus
72. Studies of defective tolerance induction in NZB mice: Evidence for a marrow pre‐T cell defect
73. NZB T cells actively interfere with the establishment of tolerance to BGG in radiation chimeras
74. The regulatory role of NZB T lymphocytes in the production of anti‐DNA antibodies in vitro
75. Elevated levels of endogenous IL‐6 in systemic lupus erythematosus
76. Spontaneous production of interleu‐kin‐10 by B lympbocytes and monocytes in systemic lupus erythematosus
77. Autoantibodies encoded by the most JH proximal human immunoglobulin heavy chain variable region gene
78. Monoclonal autoantibodies to subnucleosomes from MRL/Mp +/+ mouse: oligoclonality of the response and recognition of a determinant composed of histones H2A, H2B and DNA
79. Breaking of T cell tolerance with foreign and self co‐immunogens: a study of autoimmune B and T cell epitopes of cytochrome c
80. Structure‐function studies on a polyreactive (Natural) autoantibody
81. Independent expression of autoantibodies in SLE
82. 1 and MRL/MpJ‐lpr/lpr mice
83. Determinants of anti‐DNA antibody responses
84. The influence of DNA structure on the in vitro stimulation of murine lymphocytes by natural and synthetic polynucleotide antigens
85. Plasma interleukin‐6 and rennin substrate in reactive artbritis, rheumatoid arthritis and systemic lupus erythematosus
86. Genetic studies in NZB mice. VI. Association of autoimmune traits in recombinant inbred lines
87. Studies of tolerance in autoimmune mouse strains. Chapter 12
88. Nucleosome: a major immunogen for pathogenic autoantibody‐inducing T cells of lupus
89. Abnormalities induced by the mutant gene lpr: expansion of a unique lymphocyte subset
90. Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins
91. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties
92. Antigen‐induced apoptotic death of Ly‐1 B cells responsible for autoimmune disease in transgenic mice
93. The abnormal lymphocytes in lpr mice transcribe Interferon‐gamma and tumor necrosis factor‐alpha genes spontaneously in vivo
94. Constitutive expression of IL‐6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus
95. Probing the normal and autoimmune B cell repertoire with Epstein‐Barr virus
96. Cell‐realeased non‐specific stimulators of antibody‐forming spleen cell populations
97. A singel germline VH gene segment of normal A/J mice encodes autoantibodies characteristic of systemic lupus erythematosus
98. Immune complexes can trigger specific T cell‐dependent autoanti‐Ig antibody production in mice
99. The lymphoprol‐iferating cells of MKL‐lpr/lpr mice are a polyclonal population that bear the T lymphocyte receptor for antigen
100. Abnormal production of B cell growth factor in patients with systemic lupus erythematosus
101. A transgenic model of autoimmune hemolytic anemia
102. Polyreactive autoantibodies are nephritogenic in murine lupus nephritis
103. Immunological regulation of spontaneous antibodies to DNA and RNA. II. Sequential switch from IgM to IgG in NZB/NZW Fl mice
104. The antibody response to polyinosinic polycytidylic acid
105. IL‐4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by THI or TH2 human T cell clones
106. Pleiotropy and redundancy: T cell‐derived lymphokines in the immune response
107. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni
108. The B‐cell repertoire for autoantibodies: frequency of precursor cells for anti‐DNA antibodies
109. Lymphocytes capable of making monoclonal autoantibodies that react with multiple organs are a common feature of the normal B cell repertoire
110. Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype
111. B‐cell dependence on and response to accessory signals in murine lupus strains
112. Pathogenic autoantibody‐inducing gamma/ delta T helper cells from patients with lupus nephritis express unusual T cell receptors
113. Effects of the lpr mutaion on elimination and inactivation of self‐reactive B cells
114. Genetic studies in NZB mice. I. Spontaneous autoantibody production
115. Flow cytometric analysis of JM vivo activation of murine spleen cells
116. Cell cycle analysis of lymphocyte activation in normal and autoimmune strains
117. Genetic studies in NZB mice. V Recombinant inbred lines demonstrate that separate genes control autoimmune phenotype
118. B‐lymphocyte alloantigens accociated with systemic lupus erythematosus
119. Family studies of B lymphocyte alloantigens in systemic lupus erythematosus
120. Lupus erythematosus (LE) factors recognize both nucleosomes and viable human leukocytes
121. Repair of DNA damage induced in systemic lupus erythematosus skin fibroblasts by simulated sunlight
122. The relation of Ig class, pattern of anti‐nuclear antibody and complement fixing antibodies to DNA in sera from patients with SLE
123. A substantial proportion of the adult BALB/c available B cell repertoire consists of multireactive B cells
124. Accumulation of guanine‐cytosine‐enricbed low M.W. DNA fragments in lymphocytes of patients with systemic lupus erythematosus
125. Induction of lupus‐associated autoantibodies in Balb/c mice by intraperitoneal injection of pristane
126. − population
127. neg bone marrow cells
128. Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus‐prone mice
129. The mechanism of autoantibody production in an autoimmune MRL/ lpr mouse
130. Analysis of somatic mutation and class switching in naive and memory cells generating adoptive primary and secondary repsonses
131. Autoimmunity ‐A perspective
132. Induction of autoimmunity in normal mice by thymectomy and administration of polyclonal B cell activators: Association with contrasuppressor function
133. Interferon gamma and B cell stimulatory factor‐l reciprocally regulate Ig isotype production
134. Plasma concentration of IL‐6 in systemic lupus erythematosus,; an indicator of diesease activity
135. Letter to the editor on the genesis of auto‐antibodies
136. The pathogenesis of autoimmunity in New Zealand mice. I. Induction of anti‐nucleic acid antibodies by polyinosinic pholycytidylic acid
137. Cyclophosphamide tolerance as a test for antigenicity of nucleic acids
138. Systemic lupus erythematosus
139. MRL‐lpr/lpr disease: Theories meet Fas
140. Systemic lupus erythematosus
141. Systemic lupus erythematosus: Insights from animal models
142. Effects of ihymectomy or androgen administration upon the autoimmune disease of MRVMp‐lpr/lpr mice
143. Theoretical and experimental approaches to generalized autoimmunity
144. Studies of congenic MRL/lpr/lpr exd mice
145. The pathogenesis of autoimmunity in New Zealand mice. III. Factors influencing the formation of antinucleic acid antibodies
146. Changes in immunoglobulin class and subclass of anti‐DNA antibodies to DNA and RNA. II Sequental switch from IgM to IgG in NZBAV FI mice
147. Monoclonal anti‐DNA antibodies: The targets and origins of SLE autoantibodies
148. IgG 1 plasmacytosis in interleukin 6 transgenic mice
149. Anti‐DNA antibody production by CD5 + and CD5‐ B cells of patients with systemic lupus erythematosus
150. Interieukin‐6 and acute phase proteins in the diesease course of patients with systemic lupus erythemalosus
151. ‘Systemic lupus erythematosus’
152. IL‐4 suppresses IL‐2 and IFNgamma production by naive T cells stimulated by accessory cell‐dependent receptor engagement
153. Production of B‐cell stimulatory factors by B cells in patients with SLE
154. Immune complexes in human disease
155. Etiopathogenesis of murine systemic lupus erythematosus
156. Molecular genetics of murine lupus models
157. Expression of lymphokine genes in splenic lymphocytes of autoimmune mice
158. Hybrids from normal, germ free, nude and neonatal mice produce monoclonal autoantibodies to eight different intracellular structures
159. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
160. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity
161. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene
162. Correction of autoimmune disease by early replacement of the mutated Ipr gene with the normal/fls apoptosis gene in the T‐cells of transgenic
163. Up‐regulated MHC‐class II expression and gamma‐IFN and soluble 1L‐2R in lupus nephritis
164. Tolerance defect in SEB‐induced T cells of MRL‐lpr/lpr mice after neonatal SEB